Log In
BCIQ
Print this Print this
 

VY-SMN101

  Manage Alerts
Collapse Summary General Information
Company Voyager Therapeutics Inc.
DescriptionAdeno-associated virus (AAV)-based gene therapy targeting survival of motor neuron 1 telomeric (SMN1)
Molecular Target Survival of motor neuron 1 telomeric (SMN1)
Mechanism of Action 
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationSpinal muscular atrophy (SMA)
Indication DetailsTreat spinal muscular atrophy (SMA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today